SFA
GMAB icon

Sequoia Financial Advisors’s Genmab GMAB Stock Holding History

Sequoia Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Sell
25,599
-1,537
-6% -$40.8K ﹤0.01% 1111
2026
Q1 		$728K Sell
27,136
-5,201
-16% -$156K ﹤0.01% 1050
2025
Q4 		$996K Buy
32,337
+5,941
+23% +$185K 0.01% 886
2025
Q3 		$810K Buy
26,396
+5,977
+29% +$146K ﹤0.01% 890
2025
Q2 		$422K Sell
20,419
-1,704
-8% -$35K ﹤0.01% 1091
2025
Q1 		$433K Sell
22,123
-81
-0.4% -$1.7K ﹤0.01% 913
2024
Q4 		$463K Buy
22,204
+4,835
+28% +$106K ﹤0.01% 834
2024
Q3 		$423K Sell
17,369
-21
-0.1% -$561 ﹤0.01% 815
2024
Q2 		$437K Sell
17,390
-2,417
-12% -$68.5K 0.01% 748
2024
Q1 		$592K Sell
19,807
-22,557
-53% -$663K 0.01% 628
2023
Q4 		$1.35M Buy
42,364
+20,514
+94% +$644K 0.02% 446
2023
Q3 		$771K Buy
21,850
+1,557
+8% +$59.3K 0.01% 399
2023
Q2 		$771K Buy
20,293
+666
+3% +$26.6K 0.01% 402
2023
Q1 		$741K Sell
19,627
-888
-4% -$34.1K 0.02% 374
2022
Q4 		$869K Buy
+20,515
New +$845K 0.02% 318
2022
Q2 		– Sell
-8,738
Closed -$316K – 625
2022
Q1 		$316K Buy
8,738
+2,985
+52% +$102K 0.01% 486
2021
Q4 		$228K Buy
+5,753
New +$240K 0.01% 521
2021
Q3 		– Sell
-5,053
Closed -$206K – 328
2021
Q2 		$206K Buy
+5,053
New +$195K 0.01% 443

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sequoia Financial Advisors's GMAB Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Genmab (GMAB) stake by 5.7% in Q2 2026, selling an estimated $40.8K and leaving 25,599 shares worth $703K. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Sequoia Financial Advisors first reported a position in GMAB in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.35M in Q4 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Sequoia Financial Advisors held 25,599 shares of Genmab worth $703K as of Q2 2026.
  • Sequoia Financial Advisors sold 1,537 Genmab shares in Q2 2026, an estimated $40.8K.
  • Genmab made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1111 holding.
  • Sequoia Financial Advisors first reported a position in Genmab in Q2 2021 and has held it in 18 quarters since.
  • Sequoia Financial Advisors's Genmab position peaked at $1.35M in Q4 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.